|
Jun 20
|
LAVA Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
|
|
May 30
|
LAVA Therapeutics to Participate in the Jefferies Global Healthcare Conference
|
|
May 6
|
LAVA Therapeutics to Participate in the Citizens JMP Life Sciences Conference
|
|
Mar 21
|
LAVA Therapeutics Full Year 2023 Earnings: Revenues Disappoint
|
|
Mar 20
|
LAVA Provides Business Updates and Reports Fourth Quarter and Year-End Financial Results
|
|
Mar 5
|
LAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052 (formerly SGN-EGFRd2/LAVA-1223)
|